Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 May 2026 for Alto Neuroscience, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Amit Etkin: trading record in brief
Amit Etkin (chief executive) discloses dealings in Alto Neuroscience, Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 6 February 2024 to 14 May 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 15 May 2026, the filings show a transaction in Alto Neuroscience, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Amit Etkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
400,000 shares0Common StockSEC:0002007795-26-000006:0
6,227 shares@ US$19.69100.0% of flowCommon StockSEC:0002007795-26-000002:0
34,711 shares0Common StockSEC:0001415889-24-006822:0
11,777 sharesCommon StockSEC:0001415889-24-002934:0
4 of 4 declarations
